FOR IMMEDIATE RELEASE
Media contact:
Heather Robbins
(561) 630-7739
Heather@sbrandstrategies.com
JUPITER, FLA. (JUNE 4, 2014) –
Jupiter Medical Center has partnered with Scripps Florida, a division of The Scripps Research
Institute, to conduct a clinical trial from surgical tissue specimens
of the breast and the lung to identify targets for development and testing
of therapeutics. Results from the trial will help the medical community
better understand how therapies work and how to most effectively manage
and treat cancers.
Eligibility is voluntary and open to participants who are over the age
of 18, will undergo a tissue biopsy or surgery to determine the presence
of cancerous lesions, and have not received anti-cancer therapy in the
past five years. All participants sign an informed consent to provide
their tissue to research after pathology review.
In the trial, titled “JMC-Xeno 01: Development of patient-derived
tissue transplant models for lung and breast cancer,” research scientists
at Scripps Florida will analyze the tissue from the biopsy to learn more
about cancer mutations affecting DNA, RNA and protein expression in tumors.
There is great potential for future cancer treatments that may someday
benefit patients, according to Jupiter Medical Center’s Clinical
Research Department. For more information on the clinical trials conducted
at Jupiter Medical Center, contact Jupiter Medical Center’s Clinical
Research Department at (561) 263-5791 or visit jupitermed.com/clinical-research.
About Jupiter Medical Center's Clinical Research Program
Access to clinical trials is an integral component of Jupiter Medical Center’s
(JMC) mission to improve the health and well-being of the community. Clinical
trials may offer the opportunity to receive a new or potentially more
effective therapy for diseases and certain medical conditions. JMC participates
in national clinical studies addressing many aspects of cancer care, including
new forms of treatment, methods of prevention, ways of screening for cancer
and ways to improve comfort and quality of life for patients. Clinical
trials offered at Jupiter Medical Center include oncology-related trials,
disease-specific trials such as surgery studies, biospecimen trials, hyperbaric
oxygen trials, infectious disease studies and prevention trials. For more
information on the Clinical Research Program, visit
jupitermed.com/clinical-research.
About Jupiter Medical Center
A not-for-profit 283-bed regional medical center consisting of 163 private
acute care hospital beds and 120 long-term care, sub-acute rehabilitation
and Hospice beds, Jupiter Medical Center provides a broad range of services
with specialty concentrations in oncology, imaging, orthopedics &
spine, digestive health, emergency services, lung & thoracic, women’s
health, weight management and men’s health. Founded in 1979, the
Medical Center has approximately 1,500 team members, 575 physicians and
640 volunteers. For more information on Jupiter Medical Center, please
call (561) 263-2234 or visit
Jupitermed.com.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world's largest
independent, not-for-profit organizations focusing on research in the
biomedical sciences. TSRI is internationally recognized for its contributions
to science and health, including its role in laying the foundation for
new treatments for cancer, rheumatoid arthritis, hemophilia, and other
diseases. An institution that evolved from the Scripps Metabolic Clinic
founded by philanthropist Ellen Browning Scripps in 1924, the institute
now employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter,
FL, where its renowned scientists—including three Nobel laureates—work
toward their next discoveries. The institute's graduate program, which
awards PhD degrees in biology and chemistry, ranks among the top ten of
its kind in the nation. For more information, see www.scripps.edu.
Press Release (PDF)